Single-Nucleotide Polymorphisms in Genes Encoding Toll-Like Receptor -2, -3, -4, and -9 in Case–Control Study with Breast Cancer

Genetic Testing and Molecular Biomarkers

Volumn 13, Issue 6, 2009, Pages 729-734

  Etokebe, Godfrey E ^a   Knežević, Jelena ^b   Petričević, Branka ^a,c   Pavelić, Jasminka ^b   Vrbanec, Damir ^c   Dembić, Zlatko ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b RUDER BO KOVI INSTITUTE   (Croatia)

^c KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

TLR2 PROTEIN, HUMAN; TLR3 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ADULT; AGED; ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; INNATE IMMUNITY; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS;

EID: 75649134626     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2009.0045     Document Type: Article

References (60)

1. Adjers K, Karjalainen J, Pessi T, et al. (2005) Epistatic effect of TLR4 and IL4 genes on the risk of asthma in females. Int Arch Allergy Immunol 138:251-256.
2. Arbour N.C., Lorenz E, Schutte B.C., et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187-191.
3. Balistreri C.R., Candore G, Colonna-Romano G, et al. (2004) Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 292:2339-2340.
4. Barber R.C., Aragaki C.C., Rivera-Chavez F.A., et al. (2004) TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 41:808-813.
5. Ben-Ali M, Barbouche M.R., Bousnina S, et al. (2004) Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 11:625-626.
6. Bogen B, Schenck K, Munthe L.A., Dembic Z (2000) Deletion of idiotype (Id)-specific T cells in multiple myeloma. Acta Oncol 39:783-788.
7. Braat H, Stokkers P, Hommes T, et al. (2005) Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients. J Mol Med 83:601-609.
8. Brand S, Staudinger T, Schnitzler F, et al. (2005) The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm Bowel Dis 11:645-652.
9. Chen Y.C., Giovannucci E, Lazarus R, et al. (2005) Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 65:11771-11778.
10. Child N.J., Yang I.A., Pulletz M.C., et al. (2003) Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem Soc Trans 31:652-653.
11. de Visser K.E., Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6:24-37.
12. Edfeldt K, Bennet A.M., Eriksson P, et al. (2004) Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 25:1447-1453.
13. Fageras Bottcher M, Hmani-Aifa M, Lindstrom A, et al. (2004) A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J Allergy Clin Immunol 114:561-567.
14. Folwaczny M, Glas J, Torok H.P., et al. (2004) Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin Exp Immunol 135:330-335.
15. Franchimont D, Vermeire S, El Housni H, et al. (2004) Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53:987-992.
16. Garantziotis S, Hollingsworth J.W., Zaas A.K., Schwartz DA (2008) The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med 59:343-359.
17. Girardi M, Oppenheim D.E., Steele C.R., et al. (2001) Regulation of cutaneous malignancy by gammadelta T cells. Science 294:605-609.
18. Hamerman J.A., Ogasawara K, Lanier LL (2005) NK cells in innate immunity. Curr Opin Immunol 17:29-35.
19. Hang J, Zhou W, Zhang H, et al. (2004) TLR4 Asp299Gly and Thr399Ile polymorphisms are very rare in the Chinese population. J Endotoxin Res 10:238-240.
20. Hartel C, Finas D, Ahrens P, et al. (2004) Polymorphisms of genes involved in innate immunity: association with preterm delivery. Mol Hum Reprod 10:911-915.
21. Hawn T.R., Wu H, Grossman J.M., et al. (2005) A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus. Proc Natl Acad Sci USA 102:10593-10597.
22. Hellmig S, Fischbach W, Goebeler-Kolve M.E., et al. (2005) Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma 46:869-872.
23. Holloway J.W., Yang I.A., Ye S (2005) Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction. Pharmacogenet Genomics 15:15-21.
24. Imahara S.D., Jelacic S, Junker C.E., O'Keefe GE (2005) The TLR4 +896 polymorphism is not associated with lipopolysaccharide hypo-responsiveness in leukocytes. Genes Immun 6:37-43.
25. Kathiresan S, Newton-Cheh C, Gerszten RE (2004) On the interpretation of genetic association studies. Eur Heart J 25:1378-1381.
26. Kiechl S, Lorenz E, Reindl M, et al. (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185-192.
27. Kikuchi K, Lian Z.X., Kimura Y, et al. (2005) Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis. J Autoimmun 24:347-352.
28. Kilding R, Akil M, Till S, et al. (2003) A biologically important single nucleotide polymorphism within the toll-like receptor-4 gene is not associated with rheumatoid arthritis. Clin Exp Rheumatol 21:340-342.
29. Kolek M.J., Carlquist J.F., Muhlestein J.B., et al. (2004) Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes. Am Heart J 148:1034-1040.
30. Lakatos P.L., Lakatos L, Szalay F, et al. (2005) Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. World J Gastroenterol 11:1489-1495.
31. Lazarus R, Vercelli D, Palmer L.J., et al. (2002) Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease. Immunol Rev 190:9-25.
32. Lin Y.C., Chang Y.M., Yu J.M., et al. (2005) Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan. Atherosclerosis 180:305-309.
33. Lorenz E, Hallman M, Marttila R, et al. (2002a) Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res 52:373-376.
34. Lorenz E, Mira J.P., Frees K.L., Schwartz DA (2002b) Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162:1028-1032.
35. Minoretti P, Gazzaruso C, Vito C.D., et al. (2006) Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci Lett 391:147-149.
36. Morange P.E., Tiret L, Saut N, et al. (2004) TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: the PRIME study. Eur J Hum Genet 12:1041-1049.
37. Netea M.G., Hijmans A, van Wissen S, et al. (2004) Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia. Eur J Clin Invest 34:94-99.
38. Noguchi E, Nishimura F, Fukai H, et al. (2004) An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 34:177-183.
39. Ogus A.C., Yoldas B, Ozdemir T, et al. (2004) The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 23:219-223.
40. Oostenbrug L.E., Drenth J.P., de Jong D.J., et al. (2005) Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis 11:567-575.
41. Ouburg S, Mallant-Hent R, Crusius J.B., et al. (2005) The toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn's disease without a major role for the Saccharomyces cerevisiae mannan-LBP-CD14-TLR4 pathway. Gut 54:439-440.
42. Park Y, Park S, Yoo E, et al. (2004) Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility. Ann NY Acad Sci 1037:170-174.
43. Pirie F.J., Pegoraro R, Motala A.A., et al. (2005) Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes. Tissue Antigens 66:125-130.
44. Radstake T.R., Franke B, Hanssen S, et al. (2004) The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum 50:999-1001.
45. Rakoff-Nahoum S, Medzhitov R (2009) Toll-like receptors and cancer. Nat Rev Cancer 9:57-63.
46. Rezazadeh M, Hajilooi M, Rafiei A, et al. (2006) TLR4 polymorphism in Iranian patients with brucellosis. J Infect 53:206-210.
47. Rudofsky G Jr., Reismann P, Witte S, et al. (2004) Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes. Diabetes Care 27:179-183.
48. Schmitt C, Humeny A, Becker C.M., et al. (2002) Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles. Clin Chem 48:1661-1667.
49. Schroder N.W., Hermann C, Hamann L, et al. (2003) High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med 81:368-372.
50. Schroder N.W., Meister D, Wolff V, et al. (2005) Chronic periodontal disease is associated with single-nucleotide polymorphisms of the human TLR-4 gene. Genes Immun 6:448-451.
51. Schroder N.W., Schumann RR (2005) Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 5:156-164.
52. Smyth M.J., Cretney E, Kershaw M.H., Hayakawa Y (2004) Cytokines in cancer immunity and immunotherapy. Immunol Rev 202:275-293.
53. Smyth M.J., Thia K.Y., Street S.E., et al. (2000) Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 192:755-760.
54. Street S.E., Trapani J.A., MacGregor D, Smyth MJ (2002) Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J Exp Med 196:129-134.
55. Sun J, Wiklund F, Zheng S.L., et al. (2005) Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Natl Cancer Inst 97:525-532.
56. Tal G, Mandelberg A, Dalal I, et al. (2004) Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 189:2057-2063.
57. Torok H.P., Glas J, Tonenchi L, et al. (2004) Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 112:85-91.
58. van der Graaf C, Kullberg B.J., Joosten L, et al. (2005) Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism. Cytokine 30:264-8
59. Zheng S.L., Augustsson-Balter K, Chang B, et al. (2004) Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the Cancer Prostate in Sweden Study. Cancer Res 64:2918-2922.
60. Zitvogel L, Tesniere A, Kroemer G (2006) Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 6:715-727.